Dejan Micic to Autoimmune Diseases
This is a "connection" page, showing publications Dejan Micic has written about Autoimmune Diseases.
Connection Strength
0.979
-
Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Lee. Ann Rheum Dis. 2023 04; 82(4):e84.
Score: 0.166
-
Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Yang et al. Ann Rheum Dis. 2023 04; 82(4):e80.
Score: 0.165
-
Response to 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Gremese et al. Ann Rheum Dis. 2023 01; 82(1):e6.
Score: 0.163
-
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2021 03; 80(3):384-391.
Score: 0.162
-
The risk of respiratory tract infections and interstitial lung disease with interleukin 12/23 and interleukin 23 antagonists in patients with autoimmune diseases: A systematic review and meta-analysis. J Am Acad Dermatol. 2021 Mar; 84(3):676-690.
Score: 0.160
-
Autoimmune gastrointestinal dysmotility due to small cell lung cancer. BMJ Case Rep. 2017 Aug 11; 2017.
Score: 0.130
-
Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. Gastrointest Endosc. 2017 Jul; 86(1):93-104.e5.
Score: 0.031